News
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei to Produce Solution-Polymerized Styrene-Butadiene Rubber Using Butadiene Derived from Plastic Waste
Asahi Kasei, a diversified Japanese multinational company, concluded an agreement with Shell Eastern Petroleum (Pte) Ltd. (hereinafter “Shell”) on November 23, 2021, regarding the supply of
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei Ultra-sustainable Nonwoven Fabric, Bemliese™, Pursues Innovation and Expansion in North America
Asahi Kasei, a diversified Japanese multinational company, announces the launch of Bemliese™, its proprietary ultra-sustainable continuous-filament cellulosic nonwoven fabric, in North America via
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei and Nara Medical University Confirm 226 nm UVC LED Efficacy Against SARS-CoV-2 and Verify Reduced Effect on Animal Skin Cells
Asahi Kasei announces the results of joint research with Nara Medical University regarding the efficacy of 226 nm ultraviolet-C (UVC) LEDs in the inactivation of the coronavirus (SARS-CoV-2) that
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Asahi Kasei Corporation, a diversified Japanese multinational, today announced that its U.S. subsidiary ZOLL Medical Corporation (“ZOLL”), a manufacturer of medical devices and related software
PLAST.VAL LOIRE : Croissance dynamique au T1 2017-2018 : +11% - Hausse de l'objectif annuel de chiffre d'affaires
